GRECO, ELIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.826
AS - Asia 3.535
EU - Europa 2.662
SA - Sud America 717
AF - Africa 574
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 41
Totale 17.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.482
SG - Singapore 1.229
CN - Cina 930
HK - Hong Kong 583
BR - Brasile 520
IT - Italia 397
PL - Polonia 368
FI - Finlandia 361
DE - Germania 257
SE - Svezia 218
UA - Ucraina 171
VN - Vietnam 153
FR - Francia 128
RU - Federazione Russa 122
NL - Olanda 101
GB - Regno Unito 97
IN - India 55
KR - Corea 47
CA - Canada 46
MX - Messico 41
TR - Turchia 39
AR - Argentina 35
ZA - Sudafrica 35
ES - Italia 31
IQ - Iraq 30
JP - Giappone 30
EC - Ecuador 29
IE - Irlanda 28
EG - Egitto 25
ID - Indonesia 25
GT - Guatemala 24
CI - Costa d'Avorio 23
IR - Iran 23
BD - Bangladesh 22
AT - Austria 21
BW - Botswana 21
RO - Romania 21
SA - Arabia Saudita 21
MD - Moldavia 20
PA - Panama 20
PR - Porto Rico 20
PY - Paraguay 20
UG - Uganda 20
AU - Australia 19
AZ - Azerbaigian 19
EE - Estonia 19
GF - Guiana Francese 19
KG - Kirghizistan 19
VE - Venezuela 19
HU - Ungheria 18
IL - Israele 18
SI - Slovenia 18
TH - Thailandia 18
AD - Andorra 17
CM - Camerun 17
CO - Colombia 17
CY - Cipro 17
DK - Danimarca 17
GR - Grecia 17
ML - Mali 17
MN - Mongolia 17
MW - Malawi 17
SN - Senegal 17
TW - Taiwan 17
ZM - Zambia 17
BJ - Benin 16
BY - Bielorussia 16
DM - Dominica 16
GM - Gambi 16
HR - Croazia 16
ME - Montenegro 16
NP - Nepal 16
SO - Somalia 16
TN - Tunisia 16
TZ - Tanzania 16
BA - Bosnia-Erzegovina 15
BE - Belgio 15
CL - Cile 15
EU - Europa 15
KZ - Kazakistan 15
MU - Mauritius 15
MZ - Mozambico 15
PE - Perù 15
PH - Filippine 15
AO - Angola 14
BG - Bulgaria 14
BO - Bolivia 14
CR - Costa Rica 14
CU - Cuba 14
IS - Islanda 14
JM - Giamaica 14
LA - Repubblica Popolare Democratica del Laos 14
LC - Santa Lucia 14
MA - Marocco 14
NZ - Nuova Zelanda 14
TJ - Tagikistan 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
YT - Mayotte 14
AM - Armenia 13
Totale 16.797
Salva come PNG Salva come JPEG
Città #
Ann Arbor 939
Woodbridge 891
Chandler 863
Ashburn 767
Houston 755
Fairfield 743
Singapore 728
Jacksonville 716
Hong Kong 564
Wilmington 422
Bytom 331
Cambridge 329
Boardman 283
Seattle 272
Princeton 230
Beijing 220
Des Moines 187
Santa Clara 183
Medford 173
Nanjing 149
Helsinki 148
Roxbury 102
Dong Ket 94
San Diego 68
New York 64
Los Angeles 58
São Paulo 54
Guangzhou 53
Nanchang 48
Munich 46
Shenyang 36
Padova 35
Hebei 33
Jiaxing 32
Changsha 28
Tianjin 27
Milan 26
Rome 25
Ho Chi Minh City 23
Jinan 23
London 23
Abidjan 22
Dublin 22
Gangdong-gu 19
Johannesburg 19
Kampala 19
Panama City 18
San Francisco 18
Andorra la Vella 17
Bishkek 17
Dakar 17
Hefei 17
Warsaw 17
Zhengzhou 17
Bamako 16
Guatemala City 16
Lusaka 16
Norwalk 16
Turin 16
Ulan Bator 16
Baku 15
Cotonou 15
Dallas 15
Gaborone 15
Shanghai 15
Amsterdam 14
Castries 14
Hanoi 14
Luanda 14
Roseau 14
Tallinn 14
Dushanbe 13
Falkenstein 13
Lilongwe 13
Managua 13
Montreal 13
Phnom Penh 13
Redwood City 13
Antananarivo 12
Cairo 12
Conakry 12
Djibouti 12
Guayaquil 12
Kingston 12
Libreville 12
Maputo 12
Minsk 12
Montevideo 12
Naples 12
Podgorica 12
San José 12
Vienna 12
Washington 12
Belo Horizonte 11
Brooklyn 11
Cayenne 11
Dar es Salaam 11
Jeddah 11
Lima 11
Mamoudzou 11
Totale 11.633
Salva come PNG Salva come JPEG
Nome #
La mutazione S59P del gene TNFRSF1A, associata alla TRAPS, causa l'attivazione costitutiva della via del segnale NFkB 252
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 201
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 200
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 182
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 167
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 165
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 157
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 157
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 154
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 153
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 151
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 149
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 145
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 144
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 143
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 142
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 141
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 137
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 137
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 136
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 136
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 135
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 135
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 134
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 134
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 130
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 130
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 128
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 127
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 126
Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays. 126
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 122
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 120
Carcinogenetic potential of the WSR cagA region. 118
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 116
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 115
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 115
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 114
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 113
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 113
Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts. 112
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 112
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 112
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 112
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 110
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 110
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 110
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 109
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 109
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 108
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 108
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 107
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 105
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 104
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 103
NT-S100A8 effects on cell signalling. 103
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 103
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 103
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 103
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 101
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 101
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 101
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 99
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 99
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 99
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 99
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 99
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 98
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 97
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 96
[Biochemical markers of gastric functioning]. 95
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 95
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 95
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 95
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 95
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 95
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 95
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 95
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 95
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 94
Gastropanel: a useful screening test in paediatric populations 93
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 93
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 93
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 92
Analogues of vitamin E epitomized by alpha-tocopherol succinate (alpha-tos) for pancreatic cancer treatment: in vitro results induce caution for in vivo application. 92
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 91
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 91
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 91
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 90
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 88
Identification of new IL12A and IL12B genes polymorphisms as host genetic factors interplaying with H. pylori 86
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 86
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 85
Synergistic effect of H. pylori infection and interleukin 12 polymorphisms for the development of gastric cancer 85
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 84
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 84
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 82
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 81
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 81
Totale 11.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.637
article - articoli 15.391
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.106 0 0 54 161 65 100 14 116 171 89 172 164
2021/20221.462 19 353 77 50 49 108 33 92 72 14 153 442
2022/20231.939 379 211 25 206 339 302 9 110 232 19 71 36
2023/20241.006 36 121 105 73 67 166 70 87 23 56 88 114
2024/20254.022 23 207 226 181 550 76 166 278 399 149 756 1.011
2025/20262.856 523 1.241 1.092 0 0 0 0 0 0 0 0 0
Totale 17.457